-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Actinium Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Actinium Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.6M, a 12.2% increase year-over-year.
- Actinium Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$45M, a 15% increase year-over-year.
- Actinium Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$51.9M, a 52.2% decline from 2022.
- Actinium Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$34.1M, a 36.6% decline from 2021.
- Actinium Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$25M, a 11.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)